Literature DB >> 18546020

Discolored leg syndrome after vaccination--descriptive epidemiology.

Jeanet M Kemmeren1, Patricia E Vermeer-de Bondt, Nicoline A T van der Maas.   

Abstract

Discoloration of the leg following vaccination is a relatively unknown entity. We carried out a study of discolored leg syndrome (DLS) during a 10-year consecutive period with the objective of characterizing DLS in infants following vaccination received in the Dutch National Vaccination Program as well as its occurrence and association with different vaccines. Discolored leg syndrome was defined as an even or patchy red, blue or purple discoloration of the leg(s) and/or leg petechiae with or without swelling. All reports of adverse events following immunization that were made to the passive surveillance system between 1994 and 2003 were included-a total of 1162 identified cases. Red, blue, purple discoloration and isolated petechiae were reported in 39, 19, 27 and 14% of these cases, respectively. Of these 1162 cases, 1105 were considered to be related to the vaccination, based on a predefined risk window with symptom onset after vaccination (48 h for discolorations and 2 weeks for petechiae). Of the 1105 cases, about 50% occurred after DTP-IPV+Hib1 vaccinations, and 30% occurred after DTP-IPV+Hib2 vaccinations. Discolored leg syndrome was frequently accompanied by fierce crying (78%). The median time interval between vaccination and the occurrence of DLS was 3.8 +/- 46.7 h, and the median duration was short (2 +/- 61.7 h). Advancing the vaccination schedule from 3 to 2 months of age caused a small increase in DLS. Discolored leg syndrome manifested mainly after the first and/or second vaccination. In addition to dose, the occurrence of DLS may be slightly age-dependent and self-limiting. The pathophysiology is unknown but may be the result of a vasomotor reaction. Future studies should elucidate the recurrence rate, identify risk factors and assess late outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18546020     DOI: 10.1007/s00431-008-0707-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Authors:  Scott A Halperin; David Scheifele; Elaine Mills; Roland Guasparini; Garry Humphreys; Luis Barreto; Bruce Smith
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

2.  Harlequin syndrome.

Authors:  M Corbett; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

Review 3.  Clinical overview of vasculitic syndromes in the pediatric age.

Authors:  D Rigante
Journal:  Eur Rev Med Pharmacol Sci       Date:  2006 Nov-Dec       Impact factor: 3.507

4.  The Vaccine Adverse Event Reporting System (VAERS).

Authors:  R T Chen; S C Rastogi; J R Mullen; S W Hayes; S L Cochi; J A Donlon; S G Wassilak
Journal:  Vaccine       Date:  1994-05       Impact factor: 3.641

5.  Monitoring the safety of vaccines: assessing the risks.

Authors:  Susan S Ellenberg; Miles M Braun
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 6.  Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism.

Authors:  K Pehr; B Moroz
Journal:  Pediatr Dermatol       Date:  1993-03       Impact factor: 1.588

7.  Local reactions after the fourth dose of acellular pertussis vaccine in South Australia.

Authors:  Michael S Gold; Sara Noonan; Maggi Osbourn; Stella Precepa; Ann E Kempe
Journal:  Med J Aust       Date:  2003-08-18       Impact factor: 7.738

8.  The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India?

Authors:  Antonio Chuh; Albert Lee; Vijay Zawar
Journal:  Pediatr Dermatol       Date:  2004 Sep-Oct       Impact factor: 1.588

9.  Harlequin syndrome: the sudden onset of unilateral flushing and sweating.

Authors:  J W Lance; P D Drummond; S C Gandevia; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

10.  Cutis marmorata telangiectatica congenita: clinical features in 35 cases.

Authors:  A C Devillers; F B de Waard-van der Spek; A P Oranje
Journal:  Arch Dermatol       Date:  1999-01
View more
  3 in total

1.  Dengue hemorrhagic fever with discolored leg syndrome in a neonate.

Authors:  Manoharan Vijoo; Ramalingam Raja; Chandrasekaran Venkatesh; Uthirakumaran Ramkumar; Palanisamy Soundararajan
Journal:  Indian J Pediatr       Date:  2013-12-13       Impact factor: 1.967

2.  Dengue hemorrhagic fever with discolored leg syndrome in a neonate: correspondence.

Authors:  J B Ghosh
Journal:  Indian J Pediatr       Date:  2014-11-23       Impact factor: 1.967

3.  Acute hemorrhagic edema of young children: a prospective case series.

Authors:  Alessandra Ferrarini; Cecilia Benetti; Pietro Camozzi; Alessandro Ostini; Giacomo D Simonetti; Gregorio P Milani; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Eur J Pediatr       Date:  2015-11-25       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.